Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Alcoholism (Phase 1/Phase 2)
Amyotrophic Lateral Sclerosis (Phase 1)
Back Pain (Phase 1)
Cardiomyopathies (Phase 2)
Coronavirus Infections (Phase 1/Phase 2)
COVID-19 (Phase 2)
Crohn Disease (Phase 2)
Dental Pulp Necrosis (Phase 2/Phase 3)
Depression (Phase 1)
Depressive Disorder, Major (Phase 1/Phase 2)
Diabetes Mellitus, Type 1 (Phase 2)
Diabetic Foot (Phase 1)
Epidermolysis Bullosa Dystrophica (Phase 1/Phase 2)
Graft vs Host Disease (Phase 2)
Heart Diseases (Phase 1)
Hematopoietic Stem Cell Transplantation (Phase 3)
Ileum (Phase 2)
Ischemic Stroke (Phase 1/Phase 2)
Kidney Transplantation (Phase 1)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Myeloid, Acute (Phase 3)
Low Back Pain (Phase 2/Phase 3)
Lupus Erythematosus, Systemic (Phase 2)
Lupus Nephritis (Phase 2)
Lymphohistiocytosis, Hemophagocytic (Phase 2)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell (Phase 2)
Mesenchymal Stem Cell Transplantation (Phase 3)
Multiple Myeloma (Phase 3)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 3)
Myocardial Ischemia (Phase 2)
Osteoarthritis, Knee (Phase 1/Phase 2)
Parkinson Disease (Phase 2)
Periapical Periodontitis (Phase 2/Phase 3)
Rectal Fistula (Phase 2)
Rectovaginal Fistula (Phase 1/Phase 2)
Respiratory Distress Syndrome (Phase 2)
Scleroderma, Systemic (Phase 1/Phase 2)
Severe Acute Respiratory Syndrome (Phase 2)
Spinal Diseases (Phase 3)
Ulcer (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue